Delivery Order 75N93021D00010-75N93021F00004

Award Date 9/1/21
Potential Completion Date 1/31/25
Potential Value $404K
Ultimate Awardee
Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost Plus Fixed Fee
Place of Performance
Birmingham, AL 35205, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $403,478.00 cost-plus-fixed-fee delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, to Southern Research Institute, a non-profit research organization. The contract is for conducting hit-to-lead progression studies on investigational agents for the treatment of HIV. This work will be performed under NIAID's Preclinical Services for HIV Therapeutics indefinite...
This is a federal contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the Department of Health and Human Services (HHS), to Southern Research Institute, a non-profit organization. The contract, valued at $275,547.00, is a delivery order under a larger Indefinite Delivery/Indefinite Quantity (IDIQ) contract vehicle for providing preclinical services related to the development of HIV therapeutics and topical microbicides. The work to be performed under...
This is a Cost Plus Fixed Fee federal delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Southern Research Institute, a non-profit research organization. The $249,997 contract is for the identification of anti-HIV lead compounds as part of NIAID's in vitro testing resource for HIV therapeutics and topical microbicides. Southern Research Institute, which holds multiple federal indefinite...
This is a federal contract award from the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Southern Research Institute, a non-profit research organization. The $257,889.11 cost-plus-fixed-fee contract is for the identification of anti-HIV lead compounds, which is part of NIAID's "In Vitro Testing Resource for HIV Therapeutics and Topical Microbicides" program. The contract has no set-aside designation and is a...
This is a cost-plus-fixed-fee delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services (HHS), to Southern Research Institute, a non-profit organization. The $684,610.00 contract is for the identification of anti-HIV therapeutics and topical microbicides, which falls under NIAID's "In Vitro Testing Resource for HIV Therapeutics and Topical Microbicides" major program. The contract has a...
This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the Department of Health and Human Services (HHS). The $254,076.51 cost-plus-fixed-fee delivery order contract was awarded to Southern Research Institute, a non-profit organization that provides advanced drug discovery and development services. The contract supports high-throughput screening to identify HIV inhibitors as part of NIAID's "In Vitro Testing...
This is a federal contract award from the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services (HHS). The $128,312.76 cost-plus-fixed-fee contract was awarded to Southern Research Institute, a non-profit organization that provides research and development services, to develop new assays for HIV therapeutics and topical microbicides. The contract does not have a set-aside designation. Southern Research Institute...
This is a cost-plus-fixed-fee delivery order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency of the U.S. Department of Health and Human Services (HHS), to Southern Research Institute, a non-profit organization based in Birmingham, Alabama. The $99,998.00 contract requires Southern Research to acquire and store chemical compound libraries, and conduct high-throughput screening to identify and characterize at least one agent that can block HIV...
This is a cost-plus-fixed-fee delivery order awarded by the National Institutes of Health's National Institute of Allergy and Infectious Diseases to Southern Research Institute, a non-profit organization, to carry out activities required for the optimization, development, and synthesis of lead candidates and analogs for in vitro testing of HIV therapeutics and topical microbicides. The award, which has no set-aside designation, has a potential value of $497,408.00 and a completion date of July...
This is a cost-plus-fixed-fee delivery order contract awarded by the Department of Health and Human Services' National Institute of Allergy and Infectious Diseases to Southern Research Institute, a non-profit organization, to carry out activities required for the optimization, development, and synthesis of lead candidates and analogs related to in vitro testing of HIV therapeutics and topical microbicides. The contract has a potential value of $1,997,772.21 and a completion date of February...

This is a cost-plus-fixed-fee delivery order awarded to Southern Research Institute by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the Department of Health and Human Services (HHS). The $404,140 contract is to conduct hit-to-lead progression studies on interventional agents for the identification of anti-HIV lead compounds under the agency's Preclinical Services for HIV Therapeutics master IDIQ contract vehicle. The contract has no set-aside designation and the ultimate completion date is January 31, 2025. Southern Research Institute, a non-profit research organization, has previously been awarded prime and subcontracts with various federal agencies including NIH, CDC, DoD, and EPA for drug discovery, assay development, and other preclinical research services.

Generated 8/23/24, 4:10 PM